SORLA antibody

Cat.#: 115506

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    SORLA antibody
  • Documents
  • Description
    SORLA Rabbit Polyclonal antibody. Positive IHC detected in human brain tissue, rat brain tissue. Positive IP detected in mouse brain tissue. Observed molecular weight by Western-blot: 300 kDa
  • Tested applications
    ELISA, IP, IHC
  • Species reactivity
    Human, Mouse, Rat; other species not tested.
  • Alternative names
    LR11 antibody; LRP9 antibody; SORL1 antibody; SORLA antibody; SorLA 1 antibody; Sortilin related receptor antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained by immunization of SORLA recombinant protein (Accession Number: NM_003105). Purification method: Antigen Affinity purified.
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    IP: 1:200-1:2000

    IHC: 1:20-1:200

  • Validations

    IP Result of anti-SORL1 (IP:Catalog No:115506, 5ug; Detection:Catalog No:115506 1:500) with mouse brain tissue lysate 10000ug.

    IP Result of anti-SORL1 (IP:Catalog No:115506, 5ug; Detection:Catalog No:115506 1:500) with mouse brain tissue lysate 10000ug.

    Immunohistochemistry of paraffin-embedded human brain slide using Catalog No:115506(SORL1 Antibody) at dilution of 1:50

    Immunohistochemistry of paraffin-embedded human brain slide using Catalog No:115506(SORL1 Antibody) at dilution of 1:50

    Immunohistochemistry of paraffin-embedded human brain slide using Catalog No:115506(SORL1 Antibody) at dilution of 1:50

    Immunohistochemistry of paraffin-embedded human brain slide using Catalog No:115506(SORL1 Antibody) at dilution of 1:50

  • Background
    SorLA also known as SorL1 or LR11, is a multiligand receptor belonging to the LDL receptor superfamily. It is also a member of vacuolar protein sorting-10 (Vps10) family and is enriched in the brain. SorLA acts as an sorting receptor for APP and prevents amyloidogenic processing of APP. Downregulation of SorLA has been found in patients with sporadic Alzheimer disease (AD). Currently SorLA has emerged as a potential target for AD therapy. (25404298)
  • References
    • Chen Y, Peng Y, Che P. α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction. Proceedings of the National Academy of Sciences of the United States of America. 111(48):17296-301. 2014.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"